Furthermore, key regulatory genes in the MAPK pathway, such as MAP2K1, MAP2K2 and SHC1, were upregulated in tumour cells positive for the three integrin receptors (Figure 6E). The gene discussed is MAP2K2; the disease is neoplasm.